This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Elite Pharmaceuticals, Inc.

Drug Names(s): oxycodone/naltrexone

Description: ELI-201 is a twice daily abuse deterrent oxycodone/naltrexone product. Elite’s abuse deterrent technology is a multi-particulate capsule which contains oxycodone, an opioid agonist, in addition to naltrexone, an opioid antagonist.

ELI-201 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug